Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21917093 | 1.00 | CTSS (0.33) | CTSSCTSKEGFRALDH1A1GAA | |
| SCHEMBL23969037 | 0.89 | MAPT (0.37) | EGFRALDH1A1GAAMAPTPKM | |
| SCHEMBL12149348 | 0.87 | MAPT (0.36) | EGFRALDH1A1GAAMAPTPKM | |
| SCHEMBL21917096 | 0.83 | MAPT (0.40) | EGFRALDH1A1GAAMAPTPKM | |
| SCHEMBL21917087 | 0.81 | KCNJ1 (0.34) | EGFRALDH1A1GAAMAPTPKM | |
| SCHEMBL21917670 | 0.81 | KCNJ1 (0.34) | EGFRALDH1A1GAAMAPTPKM | |
| SCHEMBL23968978 | 0.80 | CTSS (0.30) | CTSSCTSK | |
| SCHEMBL23968838 | 0.80 | CTSS (0.30) | CTSSCTSK | |
| SCHEMBL23968862 | 0.79 | CTSS (0.30) | CTSSCTSK | |
| SCHEMBL21917088 | 0.79 | AR (0.34) | CTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. | 2021-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | OR10J3, ESR1, ETV6 | CTSS 4077/4885CTSK 2897/4885EGFR 916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.